Aptagen, LLC is a long established biotechnology company offering aptamer (synthetic antibody) services as diagnostic and biomarker drug discovery tools. Aptamers (synthetic antibodies) are ligands of RNA, DNA, and peptide oligos that bind to a variety of target antigens and are sometimes referred to as "chemical antibodies or DNA antibodies." Aptazymes are aptamers (synthetic antibodies) with enzymatic activity. The firm Aptagen has decades of experience generating high affinity and specifically-binding aptamers for small molecules, proteins, cells, and tissues, producing target-recognition elements for diagnostics, therapeutics, and bio-industrial applications. Servicing clients ranging from research academic researchers to BigPharma companies, with aptamers an emerging technology poised to become the next evolution in diagnostics and drug discovery, Aptagen is structured around developing aptamer technology to assist in diagnosis and treatment of various diseases.
